STANDARD BIOTOOLS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$0.61
-1.61%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-16.4%
3 months
-29.6%
6 months
-34.8%
1 year
-47.0%
Year to date
-52.3%
52-week range
$0.60 – $1.68
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$239.5M
P/E
2.8
P/B
0.4
P/S
2.8
Revenue
$84.6M
Net income
$84.91M
Diluted EPS
0.22
Gross margin
50.50%
Net margin
100.40%
Return on equity
17.60%
Total debt
$28.09M
Cash
$270.03M
Free cash flow
-$82.58M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $20.1M | -$26.76M | 52.40% | -133.10% | -$10.66M |
| Mar 31, 2026 | $21.15M | $127.07M | 53.50% | 600.90% | -$47.17M |
| Dec 31, 2025 | $23.8M | $19.28M | 47.80% | 81.00% | -$1.67M |
| Sep 30, 2025 | $19.55M | -$34.69M | 48.50% | -177.40% | -$23.09M |
| Jun 30, 2025 | $21.76M | -$33.46M | 48.80% | -153.70% | -$22.56M |
| Mar 31, 2025 | $40.8M | -$26.03M | 48.40% | -63.80% | -$35.34M |
| Dec 31, 2024 | $46.72M | -$34.07M | 46.90% | -72.90% | -$17.44M |
| Sep 30, 2024 | $44.97M | -$26.94M | 51.70% | -59.90% | -$30.12M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent LAB news
All market newsNo ticker-linked stories are in the current archive.